Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2500 participants
OBSERVATIONAL
2008-01-31
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The current prognosis for this ailment is good. However he persists a mortality (\<10%) and significant morbidity, firstly related malformations (heart, kidney, for example), and secondly with particularly difficult anatomical forms (Forms long defect) .
The prevalence of this condition is estimated to be 1/2500 in 3000 live births, making an estimated ± 2,500 new cases over to 10 years in France.
The current project aims to set up a national registry (Metropolitan France and Dom Tom) to measure the prevalence of esophageal atresia among live births, phenotypic characteristics, the circumstances of their diagnosis, and their initial future at short-term during the first year of life, at which time occurs the vast majority of deaths and complications in this disease.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long Term Outcome of Easophageal Atresia : Transmics Profiles in Adolescence
NCT05995171
High-resolution Esophageal Manometry
NCT03415893
Prospective Evaluation of the Results of Multidisciplinary Follow-up After a Transitional Consultation for Esophageal Atresia
NCT06860919
Outcome Predictors of Trachea-esophageal Fistula
NCT05847101
Swallowing, Feeding and Eating in Children Born With Oesophageal Atresia/Trache-oesophageal Fistula (OA/TOF)
NCT04183621
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Esophageal atresia
data collection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
data collection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* To have a esophageal atresia
Exclusion Criteria
1 Year
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frédéric Gottrand, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Félix-Guyon
Saint-Denis, La Réunion, France
CHU Amiens-Picardie
Amiens, , France
CHU d'Angers
Angers, , France
CHRU Besançon
Besançon, , France
CHU de Bordeaux
Bordeaux, , France
CHRU Brest
Brest, , France
HFME de Lyon
Bron, , France
CHU de Caen
Caen, , France
CHU de Clermont-Ferrand
Clermont-Ferrand, , France
Hôpitaux Civils de Colmar
Colmar, , France
CHI Créteil
Créteil, , France
CHU Dijon Bourgogne
Dijon, , France
CHU de Grenoble
La Tronche, , France
AP-HP CHU Kremlin-Bicêtre
Le Kremlin-Bicêtre, , France
CH Le Mans
Le Mans, , France
CHRU,Hôpital Jeanne de Flandres
Lille, , France
CHU de Limoges
Limoges, , France
AP-HM La Timone
Marseille, , France
AP-HM Nord
Marseille, , France
CHRU de Montpellier
Montpellier, , France
CHU de Nantes
Nantes, , France
CHU de Nice
Nice, , France
CHR d'Orléans
Orléans, , France
AP-HP Armand Trousseau
Paris, , France
AP-HP Necker-Enfants malades
Paris, , France
AP-HP Robert-Debré
Paris, , France
CHU de Poitiers
Poitiers, , France
CHU de Reims
Reims, , France
CHU de Rennes
Rennes, , France
CHU de Rouen
Rouen, , France
CHU de Saint-Etienne
Saint-Priest-en-Jarez, , France
CHU de Strasbourg
Strasbourg, , France
CHU de Toulouse
Toulouse, , France
CHRU de Tours
Tours, , France
CHU de Nancy
Vandœuvre-lès-Nancy, , France
CHU de Pointe-à-Pitre
Pointe-à-Pitre, , Guadeloupe
CHU de Martinique
Fort-de-France, , Martinique
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Lejeune S, Sfeir R, Rousseau V, Bonnard A, Gelas T, Aumar M, Panait N, Rabattu PY, Irtan S, Fouquet V, Le Mandat A, Cocci SN, Habonimana E, Lamireau T, Lemelle JL, Elbaz F, Talon I, Boudaoud N, Allal H, Buisson P, Petit T, Sapin E, Lardy H, Schmitt F, Levard G, Scalabre A, Michel JL, Jaby O, Pelatan C, De Vries P, Borderon C, Fourcade L, Breaud J, Arnould M, Tolg C, Chaussy Y, Geiss S, Laplace C, Drumez E, El Mourad S, Thumerelle C, Gottrand F. Esophageal Atresia and Respiratory Morbidity. Pediatrics. 2021 Sep;148(3):e2020049778. doi: 10.1542/peds.2020-049778. Epub 2021 Aug 19.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
908362
Identifier Type: OTHER
Identifier Source: secondary_id
08.297
Identifier Type: OTHER
Identifier Source: secondary_id
Reg 2008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.